Melanoma Research Alliance
Washington
About Melanoma Research Alliance
Founded in 2007 under the auspices of the Milken Institute, with the generous support of Debra and Leon Black, the Melanoma Research Alliance exists to accelerate treatment options and find a cure for melanoma. As the largest nonprofit funder of melanoma research, it has dedicated $88 million and leveraged an additional $89.5 million towards its mission. Through its support, MRA has championed revolutions in immunotherapy, targeted therapies, novel combinations and diagnostics. Due to the ongoing support of its founders, 100 percent of donations to MRA go directly to its melanoma research program. MRA's ability to fund wide-ranging research in melanoma is amplified by unique collaborations and partnerships with individuals, private foundations, and corporations.
Company Facts
- Operating status: Active
- Company type: Non-Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $40.0M
- Last round: Series Unknown (Nov 2019)
- Website: curemelanoma.org
- Phone: +1 202-336-8935
Industries & Categories
Association, Biotechnology, Medical, Medical Device, Robotics
Social Profiles
Canonical: https://fsome.com/organization/melanoma-research-alliance-93415 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.